sparfloxacin has been researched along with Infections, Chlamydia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hattori, H; Nakamura, S; Nakata, K; Okazaki, Y | 1 |
| Barlow, D; Dimian, C; Moi, H; Perea, E; Phillips, I; Stolz, E; Weidner, W | 1 |
| Bensch, G; Chodosh, S; DeAbate, CA; Harper, L; Henry, D; Jubran, A; Talbot, GH; Tipping, D | 1 |
| Matsumoto, A; Matsushima, T; Miyashita, N | 1 |
| Arakawa, S; Fujii, A; Kamidono, S; Maeda, H; Nakata, K; Umezu, K | 1 |
2 trial(s) available for sparfloxacin and Infections, Chlamydia
| Article | Year |
|---|---|
A comparative study of two different regimens of sparfloxacin versus doxycycline in the treatment of non-gonococcal urethritis in men.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Double-Blind Method; Doxycycline; Drug Administration Schedule; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones; Ureaplasma Infections; Ureaplasma urealyticum; Urethritis | 1996 |
Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Chlamydia Infections; Chlamydophila pneumoniae; Chronic Disease; Cough; Double-Blind Method; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Moraxella catarrhalis; Neisseriaceae Infections; Ofloxacin; Placebos; Pneumococcal Infections; Quinolones; Sputum; Staphylococcal Infections; Treatment Outcome | 1998 |
3 other study(ies) available for sparfloxacin and Infections, Chlamydia
| Article | Year |
|---|---|
Protective effects of sparfloxacin in experimental pneumonia caused by Chlamydia pneumoniae in leukopenic mice.
Topics: Animals; Anti-Infective Agents; Chlamydia Infections; Chlamydophila pneumoniae; Female; Fluoroquinolones; Leukopenia; Lung; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumonia, Bacterial; Quinolones | 1994 |
In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Glycogen; Humans; Male; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Plasmids; Urethritis | 2000 |
In vitro and in vivo activities of sparfloxacin, other quinolones, and tetracyclines against Chlamydia trachomatis.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Quinolones; Tetracyclines | 1992 |